Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
Louis J Aronne , Naveed Sattar, Deborah B Horn, et al.JAMA . 2024 Jan 2;331(1):38-48. doi: 10.1001/jama.2023.24945.
Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association
Katherine A Gallagher, Joseph L Mills, David G Armstrong, et. al. Circulation. 2023 Dec 14.
https://doi.org/10.1161/CIR.0000000000001192
Standards of Care in Diabetes-2024
December 2023, Vol.47, S1-S4.
doi:https://doi.org/10.2337/dc24-SINT
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
Kutz A, Kim D,Wexler D, Liu J, Schneeweiss S, Glynn R and Patorno E
Diabetes Care 2023;46(11):2004–2014
https://doi.org/10.2337/dc23-0671
The challenges of identifying and studying type 1 diabetes in adults
ThomasJ, Jones ADiabetologia: December;2023;66: 2200 – 2212
https://doi.org/10.1007/s00125-023-06004-4
The evolving continuum of dysglycaemia: Non-diabetic hyperglycaemia in older adults
Golding J, Hope S, Chakera A and Puttana A
Diabet Med. 2023 Oct;40(10):e15177.
https://doi.org/10.1111/dme.15177
Comentarios recientes